ArticleCureus2025
From Yellow Cumulus to Pregnancy in Autoimmune Hemolytic Anemia Following Bilirubin Reduction: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune hemolytic anemia (AIHA) is a systemic condition associated with inflammation and oxidative stress, both of which can negatively affect reproductive outcomes. Bilirubin, a byproduct of hemolysis, has been implicated in oocyte maturation and embryogenesis. We present the case of a 31-year-old patient with primary infertility who was known with AIHA. She had a total bilirubin level of 60 µmol/L prior to the first stimulation cycle, which was associated with yellowish pigmentation of the cumulus cells, poor oocyte quality, and no blastocyst formation. The decline in the total bilirubin level to 48 µmol/L after prednisone therapy of 60 mg daily for three months led to improved cumulus cell appearance and enhanced oocyte and embryo quality in the second stimulation cycle. A successful pregnancy was achieved following frozen blastocyst transfer in a natural cycle. This case underscores the importance of individualized assessment and the careful interpretation of elevated bilirubin levels in the context of assisted reproductive technology, as systemic conditions may potentially impact reproductive success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.